PureTech Announces the Appointment of George Farmer, Ph.D., as Chief Financial Officer

PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that George Farmer, Ph.D., has been appointed Chief Financial Officer.

PureTech announced the appointment of George Farmer, Ph.D., as Chief Financial Officer. An experienced financial analyst and biotech executive, Dr. Farmer joins PureTech from BMO Capital Markets where he completed a 15-year career as a senior biotechnology equity analyst providing in-depth sector research for institutional investor clients. (Photo: Business Wire)

“We are delighted to welcome George to the senior leadership team as we are poised to build on the momentum of the past year,” said Daphne Zohar, Founder and Chief Executive Officer of PureTech. “This is an important moment for PureTech, as we recently initiated three clinical trials based on programs from our Wholly Owned Pipeline and expanded our presence with the NASDAQ Global Market listing. We believe that George’